Request for Covid-19 Impact Assessment of this Report

Healthcare

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Radiopharmaceutical Market 2017 Forecast to 2022

  • GLO1517988
  • 124 Pages
  • August 2017
  • Healthcare
Download Sample    Get Discount   
 
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:

This report focuses on the Radiopharmaceutical in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Bayer

Triad Isotopes

Lantheus

GE Healthcare

Mallinckrodt

Eli Lilly

Bracco Imaging

SIEMENS

Navidea

Nordion

IBA Group

Jubilant Pharma

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

SPECT Radioisotopes

PET Radioisotopes

Other Diagnostic Radioisotopes

Therapeutic Radioisotopes

Market Segment by Applications, can be divided into

Oncology

Cardiology

Other

There are 15 Chapters to deeply display the global Radiopharmaceutical market.

Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Radiopharmaceutical Introduction

1.2 Market Analysis by Type

1.2.1 SPECT Radioisotopes

1.2.2 PET Radioisotopes

1.2.3 Other Diagnostic Radioisotopes

1.2.4 Therapeutic Radioisotopes

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Cardiology

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (USA, Canada and Mexico)

1.4.1.1 USA Market States and Outlook (2012-2022)

1.4.1.2 Canada Market States and Outlook (2012-2022)

1.4.1.3 Mexico Market States and Outlook (2012-2022)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2012-2022)

1.4.2.2 France Market States and Outlook (2012-2022)

1.4.2.3 UK Market States and Outlook (2012-2022)

1.4.2.4 Russia Market States and Outlook (2012-2022)

1.4.2.5 Italy Market States and Outlook (2012-2022)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2012-2022)

1.4.3.2 Japan Market States and Outlook (2012-2022)

1.4.3.3 Korea Market States and Outlook (2012-2022)

1.4.3.4 India Market States and Outlook (2012-2022)

1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2012-2022)

1.4.4.2 Egypt Market States and Outlook (2012-2022)

1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)

1.4.4.4 South Africa Market States and Outlook (2012-2022)

1.4.4.5 Nigeria Market States and Outlook (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Business Overview

2.1.2 Radiopharmaceutical Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Triad Isotopes

2.2.1 Business Overview

2.2.2 Radiopharmaceutical Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Lantheus

2.3.1 Business Overview

2.3.2 Radiopharmaceutical Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 GE Healthcare

2.4.1 Business Overview

2.4.2 Radiopharmaceutical Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mallinckrodt

2.5.1 Business Overview

2.5.2 Radiopharmaceutical Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Eli Lilly

2.6.1 Business Overview

2.6.2 Radiopharmaceutical Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Bracco Imaging

2.7.1 Business Overview

2.7.2 Radiopharmaceutical Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 SIEMENS

2.8.1 Business Overview

2.8.2 Radiopharmaceutical Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Navidea

2.9.1 Business Overview

2.9.2 Radiopharmaceutical Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Nordion

2.10.1 Business Overview

2.10.2 Radiopharmaceutical Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 IBA Group

2.11.1 Business Overview

2.11.2 Radiopharmaceutical Type and Applications

2.11.2.1 Type 1

2.11.2.2 Type 2

2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Jubilant Pharma

2.12.1 Business Overview

2.12.2 Radiopharmaceutical Type and Applications

2.12.2.1 Type 1

2.12.2.2 Type 2

2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Radiopharmaceutical Market Competition, by Manufacturer

3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2016-2017)

3.3 Global Radiopharmaceutical Price by Manufacturer (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share

3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share

3.5 Market Competition Trend

4 Global Radiopharmaceutical Market Analysis by Regions

4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions

4.1.1 Global Radiopharmaceutical Sales by Regions (2012-2017)

4.1.2 Global Radiopharmaceutical Revenue by Regions (2012-2017)

4.2 North America Radiopharmaceutical Sales and Growth (2012-2017)

4.3 Europe Radiopharmaceutical Sales and Growth (2012-2017)

4.4 Asia-Pacific Radiopharmaceutical Sales and Growth (2012-2017)

4.5 South America Radiopharmaceutical Sales and Growth (2012-2017)

4.6 Middle East and Africa Radiopharmaceutical Sales and Growth (2012-2017)

5 North America Radiopharmaceutical by Countries, Type, Application and Manufacturers

5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Countries

5.1.1 North America Radiopharmaceutical Sales by Countries (2012-2017)

5.1.2 North America Radiopharmaceutical Revenue by Countries (2012-2017)

5.1.3 USA Radiopharmaceutical Sales and Growth (2012-2017)

5.1.4 Canada Radiopharmaceutical Sales and Growth (2012-2017)

5.1.5 Mexico Radiopharmaceutical Sales and Growth (2012-2017)

5.2 North America Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)

5.2.1 North America Radiopharmaceutical Sales by Manufacturers (2016-2017)

5.2.2 North America Radiopharmaceutical Revenue by Manufacturers (2016-2017)

5.3 North America Radiopharmaceutical Sales by Type (2012-2017)

5.4 North America Radiopharmaceutical Sales by Application (2012-2017)

6 Europe Radiopharmaceutical by Countries, Type, Application and Manufacturers

6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries

6.1.1 Europe Radiopharmaceutical Sales by Countries (2012-2017)

6.1.2 Europe Radiopharmaceutical Revenue by Countries (2012-2017)

6.1.3 Germany Radiopharmaceutical Sales and Growth (2012-2017)

6.1.4 UK Radiopharmaceutical Sales and Growth (2012-2017)

6.1.5 France Radiopharmaceutical Sales and Growth (2012-2017)

6.1.6 Russia Radiopharmaceutical Sales and Growth (2012-2017)

6.1.7 Italy Radiopharmaceutical Sales and Growth (2012-2017)

6.2 Europe Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)

6.2.1 Europe Radiopharmaceutical Sales by Manufacturers (2016-2017)

6.2.2 Europe Radiopharmaceutical Revenue by Manufacturers (2016-2017)

6.3 Europe Radiopharmaceutical Sales by Type (2012-2017)

6.4 Europe Radiopharmaceutical Sales by Application (2012-2017)

7 Asia-Pacific Radiopharmaceutical by Countries, Type, Application and Manufacturers

7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Radiopharmaceutical Sales by Countries (2012-2017)

7.1.2 Asia-Pacific Radiopharmaceutical Revenue by Countries (2012-2017)

7.1.3 China Radiopharmaceutical Sales and Growth (2012-2017)

7.1.4 Japan Radiopharmaceutical Sales and Growth (2012-2017)

7.1.5 Korea Radiopharmaceutical Sales and Growth (2012-2017)

7.1.6 India Radiopharmaceutical Sales and Growth (2012-2017)

7.1.7 Southeast Asia Radiopharmaceutical Sales and Growth (2012-2017)

7.2 Asia-Pacific Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)

7.2.1 Asia-Pacific Radiopharmaceutical Sales by Manufacturers (2016-2017)

7.2.2 Asia-Pacific Radiopharmaceutical Revenue by Manufacturers (2016-2017)

7.3 Asia-Pacific Radiopharmaceutical Sales by Type (2012-2017)

7.4 Asia-Pacific Radiopharmaceutical Sales by Application (2012-2017)

8 South America Radiopharmaceutical by Countries, Type, Application and Manufacturers

8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Countries

8.1.1 South America Radiopharmaceutical Sales by Countries (2012-2017)

8.1.2 South America Radiopharmaceutical Revenue by Countries (2012-2017)

8.1.3 Brazil Radiopharmaceutical Sales and Growth (2012-2017)

8.1.4 Argentina Radiopharmaceutical Sales and Growth (2012-2017)

8.1.5 Columbia Radiopharmaceutical Sales and Growth (2012-2017)

8.2 South America Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)

8.2.1 South America Radiopharmaceutical Sales by Manufacturers (2016-2017)

8.2.2 South America Radiopharmaceutical Revenue by Manufacturers (2016-2017)

8.3 South America Radiopharmaceutical Sales by Type (2012-2017)

8.4 South America Radiopharmaceutical Sales by Application (2012-2017)

9 Middle East and Africa Radiopharmaceutical by Countries, Type, Application and Manufacturers

9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Radiopharmaceutical Sales by Countries (2012-2017)

9.1.2 Middle East and Africa Radiopharmaceutical Revenue by Countries (2012-2017)

9.1.3 Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)

9.1.4 UAE Radiopharmaceutical Sales and Growth (2012-2017)

9.1.5 Egypt Radiopharmaceutical Sales and Growth (2012-2017)

9.1.6 Nigeria Radiopharmaceutical Sales and Growth (2012-2017)

9.1.7 South Africa Radiopharmaceutical Sales and Growth (2012-2017)

9.2 Middle East and Africa Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)

9.2.1 Middle East and Africa Radiopharmaceutical Sales by Manufacturers (2016-2017)

9.2.2 Middle East and Africa Radiopharmaceutical Revenue by Manufacturers (2016-2017)

9.3 Middle East and Africa Radiopharmaceutical Sales by Type (2012-2017)

9.4 Middle East and Africa Radiopharmaceutical Sales by Application (2012-2017)

10 Global Radiopharmaceutical Market Segment by Type

10.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)

10.1.1 Global Radiopharmaceutical Sales and Market Share by Type (2012-2017)

10.1.2 Global Radiopharmaceutical Revenue and Market Share by Type (2012-2017)

10.2 SPECT Radioisotopes Sales Growth and Price

10.2.1 Global SPECT Radioisotopes Sales Growth (2012-2017)

10.2.2 Global SPECT Radioisotopes Price (2012-2017)

10.3 PET Radioisotopes Sales Growth and Price

10.3.1 Global PET Radioisotopes Sales Growth (2012-2017)

10.3.2 Global PET Radioisotopes Price (2012-2017)

10.4 Other Diagnostic Radioisotopes Sales Growth and Price

10.4.1 Global Other Diagnostic Radioisotopes Sales Growth (2012-2017)

10.4.2 Global Other Diagnostic Radioisotopes Price (2012-2017)

10.5 Therapeutic Radioisotopes Sales Growth and Price

10.5.1 Global Therapeutic Radioisotopes Sales Growth (2012-2017)

10.5.2 Global Therapeutic Radioisotopes Price (2012-2017)

11 Global Radiopharmaceutical Market Segment by Application

11.1 Global Radiopharmaceutical Sales Market Share by Application (2012-2017)

11.2 Oncology Sales Growth (2012-2017)

11.3 Cardiology Sales Growth (2012-2017)

11.4 Other Sales Growth (2012-2017)

12 Radiopharmaceutical Market Forecast (2017-2022)

12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)

12.2 Radiopharmaceutical Market Forecast by Regions (2017-2022)

12.2.1 North America Radiopharmaceutical Market Forecast (2017-2022)

12.2.2 Europe Radiopharmaceutical Market Forecast (2017-2022)

12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2017-2022)

12.2.4 South America Radiopharmaceutical Market Forecast (2017-2022)

12.2.5 Middle East and Africa Radiopharmaceutical Market Forecast (2017-2022)

12.3 Radiopharmaceutical Market Forecast by Type (2017-2022)

12.4 Radiopharmaceutical Market Forecast by Application (2017-2022)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data Source

List of Tables and Figures

Figure Radiopharmaceutical Picture

Table Product Specifications of Radiopharmaceutical

Figure Global Sales Market Share of Radiopharmaceutical by Types in 2016

Table Radiopharmaceutical Types for Major Manufacturers

Figure SPECT Radioisotopes Picture

Figure PET Radioisotopes Picture

Figure Other Diagnostic Radioisotopes Picture

Figure Therapeutic Radioisotopes Picture

Table Radiopharmaceutical Sales Market Share by Applications in 2016

Figure Oncology Picture

Figure Cardiology Picture

Figure Other Picture

Figure USA Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Canada Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Mexico Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Germany Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure France Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure UK Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Russia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Italy Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure China Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Japan Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Korea Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure India Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Southeast Asia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Brazil Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Egypt Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Saudi Arabia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure South Africa Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Figure Nigeria Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Radiopharmaceutical Type and Applications

Table Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Triad Isotopes Basic Information, Manufacturing Base and Competitors

Table Triad Isotopes Radiopharmaceutical Type and Applications

Table Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Lantheus Basic Information, Manufacturing Base and Competitors

Table Lantheus Radiopharmaceutical Type and Applications

Table Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GE Healthcare Basic Information, Manufacturing Base and Competitors

Table GE Healthcare Radiopharmaceutical Type and Applications

Table GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mallinckrodt Basic Information, Manufacturing Base and Competitors

Table Mallinckrodt Radiopharmaceutical Type and Applications

Table Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Radiopharmaceutical Type and Applications

Table Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bracco Imaging Basic Information, Manufacturing Base and Competitors

Table Bracco Imaging Radiopharmaceutical Type and Applications

Table Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table SIEMENS Basic Information, Manufacturing Base and Competitors

Table SIEMENS Radiopharmaceutical Type and Applications

Table SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Navidea Basic Information, Manufacturing Base and Competitors

Table Navidea Radiopharmaceutical Type and Applications

Table Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Nordion Basic Information, Manufacturing Base and Competitors

Table Nordion Radiopharmaceutical Type and Applications

Table Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IBA Group Basic Information, Manufacturing Base and Competitors

Table IBA Group Radiopharmaceutical Type and Applications

Table IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Jubilant Pharma Basic Information, Manufacturing Base and Competitors

Table Jubilant Pharma Radiopharmaceutical Type and Applications

Table Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Radiopharmaceutical Sales by Manufacturer (2016-2017)

Figure Global Radiopharmaceutical Sales Market Share by Manufacturer in 2016

Figure Global Radiopharmaceutical Sales Market Share by Manufacturer in 2017

Table Global Radiopharmaceutical Revenue by Manufacturer (2016-2017)

Figure Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2016

Figure Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2017

Table Global Radiopharmaceutical Price by Manufacturer (2016-2017)

Figure Global Radiopharmaceutical Sales and Growth (2012-2017)

Figure Global Radiopharmaceutical Revenue and Growth (2012-2017)

Table Global Radiopharmaceutical Sales by Regions (2012-2017)

Table Global Radiopharmaceutical Sales Market Share by Regions (2012-2017)

Table Global Radiopharmaceutical Revenue by Regions (2012-2017)

Figure Global Radiopharmaceutical Revenue Market Share by Regions in 2012

Figure Global Radiopharmaceutical Revenue Market Share by Regions in 2016

Figure North America Radiopharmaceutical Sales and Growth (2012-2017)

Figure Europe Radiopharmaceutical Sales and Growth (2012-2017)

Figure Asia-Pacific Radiopharmaceutical Sales and Growth (2012-2017)

Figure South America Radiopharmaceutical Sales and Growth (2012-2017)

Figure Middle East and Africa Radiopharmaceutical Sales and Growth (2012-2017)

Figure North America Radiopharmaceutical Revenue and Growth (2012-2017)

Table North America Radiopharmaceutical Sales by Countries (2012-2017)

Table North America Radiopharmaceutical Sales Market Share by Countries (2012-2017)

Figure North America Radiopharmaceutical Sales Market Share by Countries in 2012

Figure North America Radiopharmaceutical Sales Market Share by Countries in 2016

Table North America Radiopharmaceutical Revenue by Countries (2012-2017)

Table North America Radiopharmaceutical Revenue Market Share by Countries (2012-2017)

Figure North America Radiopharmaceutical Revenue Market Share by Countries in 2012

Figure North America Radiopharmaceutical Revenue Market Share by Countries in 2016

Figure USA Radiopharmaceutical Sales and Growth (2012-2017)

Figure Canada Radiopharmaceutical Sales and Growth (2012-2017)

Figure Mexico Radiopharmaceutical Sales and Growth (2012-2017)

Table North America Radiopharmaceutical Sales by Manufacturer (2016-2017)

Figure North America Radiopharmaceutical Sales Market Share by Manufacturer in 2016

Figure North America Radiopharmaceutical Sales Market Share by Manufacturer in 2017

Table North America Radiopharmaceutical Revenue by Manufacturer (2016-2017)

Figure North America Radiopharmaceutical Revenue Market Share by Manufacturer in 2016

Figure North America Radiopharmaceutical Revenue Market Share by Manufacturer in 2017

Table North America Radiopharmaceutical Sales by Type (2012-2017)

Table North America Radiopharmaceutical Sales Share by Type (2012-2017)

Table North America Radiopharmaceutical Sales by Application (2012-2017)

Table North America Radiopharmaceutical Sales Share by Application (2012-2017)

Figure Europe Radiopharmaceutical Revenue and Growth (2012-2017)

Table Europe Radiopharmaceutical Sales by Countries (2012-2017)

Table Europe Radiopharmaceutical Sales Market Share by Countries (2012-2017)

Table Europe Radiopharmaceutical Revenue by Countries (2012-2017)

Table Europe Radiopharmaceutical Revenue Market Share by Countries in 2012

Table Europe Radiopharmaceutical Revenue Market Share by Countries in 2016

Figure Germany Radiopharmaceutical Sales and Growth (2012-2017)

Figure UK Radiopharmaceutical Sales and Growth (2012-2017)

Figure France Radiopharmaceutical Sales and Growth (2012-2017)

Figure Russia Radiopharmaceutical Sales and Growth (2012-2017)

Figure Italy Radiopharmaceutical Sales and Growth (2012-2017)

Table Europe Radiopharmaceutical Sales by Manufacturer (2016-2017)

Figure Europe Radiopharmaceutical Sales Market Share by Manufacturer in 2016

Figure Europe Radiopharmaceutical Sales Market Share by Manufacturer in 2017

Table Europe Radiopharmaceutical Revenue by Manufacturer (2016-2017)

Figure Europe Radiopharmaceutical Revenue Market Share by Manufacturer in 2016

Figure Europe Radiopharmaceutical Revenue Market Share by Manufacturer in 2017

Table Europe Radiopharmaceutical Sales by Type (2012-2017)

Table Europe Radiopharmaceutical Sales Share by Type (2012-2017)

Table Europe Radiopharmaceutical Sales by Application (2012-2017)

Table Europe Radiopharmaceutical Sales Share by Application (2012-2017)

Figure Asia-Pacific Radiopharmaceutical Revenue and Growth (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales by Countries (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales Market Share by Countries (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales Market Share by Countries (2012-2017)

Table Asia-Pacific Radiopharmaceutical Revenue by Countries (2012-2017)

Table Asia-Pacific Radiopharmaceutical Revenue Market Share by Countries (2012-2017)

Figure China Radiopharmaceutical Sales and Growth (2012-2017)

Figure Japan Radiopharmaceutical Sales and Growth (2012-2017)

Figure Korea Radiopharmaceutical Sales and Growth (2012-2017)

Figure India Radiopharmaceutical Sales and Growth (2012-2017)

Figure Southeast Asia Radiopharmaceutical Sales and Growth (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales by Manufacturer (2016-2017)

Figure Asia-Pacific Radiopharmaceutical Sales Market Share by Manufacturer in 2016

Figure Asia-Pacific Radiopharmaceutical Sales Market Share by Manufacturer in 2017

Table Asia-Pacific Radiopharmaceutical Revenue by Manufacturer (2016-2017)

Figure Asia-Pacific Radiopharmaceutical Revenue Market Share by Manufacturer in 2016

Figure Asia-Pacific Radiopharmaceutical Revenue Market Share by Manufacturer in 2017

Table Asia-Pacific Radiopharmaceutical Sales by Type (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales Share by Type (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales by Application (2012-2017)

Table Asia-Pacific Radiopharmaceutical Sales Share by Application (2012-2017)

Figure South America Radiopharmaceutical Revenue and Growth (2012-2017)

Table South America Radiopharmaceutical Sales by Countries (2012-2017)

Table South America Radiopharmaceutical Sales Market Share by Countries (2012-2017)

Figure South America Radiopharmaceutical Sales Market Share by Countries in 2016

Table South America Radiopharmaceutical Revenue by Countries (2012-2017)

Table South America Radiopharmaceutical Revenue Market Share by Countries (2012-2017)

Figure South America Radiopharmaceutical Revenue Market Share by Countries in 2016

Figure South America Radiopharmaceutical Revenue Market Share by Countries in 2017

Figure Brazil Radiopharmaceutical Sales and Growth (2012-2017)

Figure Argentina Radiopharmaceutical Sales and Growth (2012-2017)

Figure Columbia Radiopharmaceutical Sales and Growth (2012-2017)

Table South America Radiopharmaceutical Sales by Manufacturer (2016-2017)

Figure South America Radiopharmaceutical Sales Market Share by Manufacturer in 2016

Figure South America Radiopharmaceutical Sales Market Share by Manufacturer in 2017

Table South America Radiopharmaceutical Revenue by Manufacturer (2016-2017)

Figure South America Radiopharmaceutical Revenue Market Share by Manufacturer in 2016

Figure South America Radiopharmaceutical Revenue Market Share by Manufacturer in 2017

Table South America Radiopharmaceutical Sales by Type (2012-2017)

Table South America Radiopharmaceutical Sales Share by Type (2012-2017)

Table South America Radiopharmaceutical Sales by Application (2012-2017)

Table South America Radiopharmaceutical Sales Share by Application (2012-2017)

Figure Middle East and Africa Radiopharmaceutical Revenue and Growth (2012-2017)

Table Middle East and Africa Radiopharmaceutical Sales by Countries (2012-2017)

Table Middle East and Africa Radiopharmaceutical Sales Market Share by Countries (2012-2017)

Figure Middle East and Africa Radiopharmaceutical Sales Market Share by Countries in 2016

Table Middle East and Africa Radiopharmaceutical Revenue by Countries (2012-2017)

Table Middle East and Africa Radiopharmaceutical Revenue Market Share by Countries (2012-2017)

Figure Middle East and Africa Radiopharmaceutical Revenue Market Share by Countries in 2012

Figure Middle East and Africa Radiopharmaceutical Revenue Market Share by Countries in 2016

Figure Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)

Figure UAE Radiopharmaceutical Sales and Growth (2012-2017)

Figure Egypt Radiopharmaceutical Sales and Growth (2012-2017)

Figure Nigeria Radiopharmaceutical Sales and Growth (2012-2017)

Figure South Africa Radiopharmaceutical Sales and Growth (2012-2017)

Table Middle East and Africa Radiopharmaceutical Sales by Manufacturer (2016-2017)

Figure Middle East and Africa Radiopharmaceutical Sales Market Share by Manufacturer in 2016

Figure Middle East and Africa Radiopharmaceutical Sales Market Share by Manufacturer in 2017

Table Middle East and Africa Radiopharmaceutical Revenue by Manufacturer (2016-2017)

Figure Middle East and Africa Radiopharmaceutical Revenue Market Share by Manufacturer in 2016

Figure Middle East and Africa Radiopharmaceutical Revenue Market Share by Manufacturer in 2017

Table Middle East and Africa Radiopharmaceutical Sales by Type (2012-2017)

Table Middle East and Africa Radiopharmaceutical Sales Share by Type (2012-2017)

Table Middle East and Africa Radiopharmaceutical Sales by Application (2012-2017)

Table Middle East and Africa Radiopharmaceutical Sales Share by Application (2012-2017)

Table Global Radiopharmaceutical Sales by Type (2012-2017)

Table Global Radiopharmaceutical Sales Share by Type (2012-2017)

Table Global Radiopharmaceutical Revenue by Type (2012-2017)

Table Global Radiopharmaceutical Revenue Share by Type (2012-2017)

Figure Global SPECT Radioisotopes Sales Growth (2012-2017)

Figure Global SPECT Radioisotopes Price (2012-2017)

Figure Global PET Radioisotopes Sales Growth (2012-2017)

Figure Global PET Radioisotopes Price (2012-2017)

Figure Global Other Diagnostic Radioisotopes Sales Growth (2012-2017)

Figure Global Other Diagnostic Radioisotopes Price (2012-2017)

Figure Global Therapeutic Radioisotopes Sales Growth (2012-2017)

Figure Global Therapeutic Radioisotopes Price (2012-2017)

Table Global Radiopharmaceutical Sales by Application (2012-2017)

Table Global Radiopharmaceutical Sales Share by Application (2012-2017)

Figure Global Oncology Sales Growth (2012-2017)

Figure Global Cardiology Sales Growth (2012-2017)

Figure Global Other Sales Growth (2012-2017)

Figure Global Radiopharmaceutical Sales, Revenue and Growth Rate (2017 -2022)

Table Global Radiopharmaceutical Sales Forecast by Regions (2017-2022)

Table Global Radiopharmaceutical Market Share Forecast by Regions (2017-2022)

Figure North America Sales Radiopharmaceutical Market Forecast (2017-2022)

Figure Europe Sales Radiopharmaceutical Market Forecast (2017-2022)

Figure Asia-Pacific Sales Radiopharmaceutical Market Forecast (2017-2022)

Figure South America Sales Radiopharmaceutical Market Forecast (2017-2022)

Figure Middle East and Africa Sales Radiopharmaceutical Market Forecast (2017-2022)

Table Global Radiopharmaceutical Sales Forecast by Type (2017-2022)

Table Global Radiopharmaceutical Market Share Forecast by Type (2017-2022)

Table Global Radiopharmaceutical Sales Forecast by Application (2017-2022)

Table Global Radiopharmaceutical Market Share Forecast by Application (2017-2022)

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370